Screening, prevention and management of osteoporosis and bone loss in adult and pediatric hematopoietic cell transplant recipients. (Q37781691)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20729922%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

title

Screening, prevention and management of osteoporosis and bone loss in adult and pediatric hematopoietic cell transplant recipients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20729922%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20729922%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

B L McClune

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20729922%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

L E Polgreen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20729922%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

A H Blaes

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20729922%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

D A Mulrooney

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20729922%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

L J Burns

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20729922%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

N S Majhail

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20729922%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

language of work or name

English

0 references

publication date

23 August 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20729922%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

11 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20729922%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20729922%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20729922%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

1-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20729922%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bmt.2010.198

11 February 2020

exact match

0 references

cites work

Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Dual energy X-ray absorptiometry interpretation and reporting in children and adolescents: the 2007 ISCD Pediatric Official Positions.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Pediatric Position Development Conference

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Clinical use of bone densitometry: scientific review

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Hip fracture in women without osteoporosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Mechanisms of osteoporosis after hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Prospective Study of Changes in Bone Mineral Density and Turnover in Children after Hematopoietic Cell Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

The effect of hormone replacement therapy on bone mass in patients with ovarian failure due to bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Loss of bone mass and vitamin D deficiency after hematopoietic stem cell transplantation: standard prophylactic measures fail to prevent osteoporosis.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Effects of various antireabsorptive treatments on bone mineral density in hypogonadal young women after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Beneficial treatment with risedronate in long-term survivors after allogeneic stem cell transplantation for hematological malignancies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: effect of calcium supplementation with or without calcitonin

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Accelerated bone mineral density loss occurs with similar incidence and severity, but with different risk factors, after autologous versus allogeneic hematopoietic cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Bone loss and its management in long-term survivors from allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Pamidronate reduces bone loss after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Prevention of bone loss after allogeneic stem cell transplantation by calcium, vitamin D, and sex hormone replacement with or without pamidronate.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Pilot study on the use of zoledronic acid to prevent bone loss in allo-SCT recipients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Zoledronic acid prevents bone loss after allogeneic haemopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Bone loss following hematopoietic stem cell transplantation: a long-term follow-up.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Short-term zoledronic acid treatment increases bone mineral density and marrow clonogenic fibroblast progenitors after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Increased risk of bone loss without fracture risk in long-term survivors after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Significant and persistent loss of bone mineral density in the femoral neck after haematopoietic stem cell transplantation: long‐term follow‐up of a prospective study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Loss of bone mineral density and secondary hyperparathyroidism are complications of autologous stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Decreased bone mineral density is common after autologous blood or marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Endocrine function and bone metabolism 5 years after autologous bone marrow/blood-derived progenitor cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Effects of allogeneic bone marrow transplantation on recipient bone mineral density: A prospective study.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Allogeneic bone marrow transplantation is associated with a preferential femoral neck bone loss

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Pharmacologic treatment of low bone density or osteoporosis to prevent fractures: a clinical practice guideline from the American College of Physicians

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Bisphosphonates for steroid induced osteoporosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

The epidemiology of glucocorticoid-associated adverse events

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Fracture risk with intermittent high-dose oral glucocorticoid therapy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Assessment of fracture risk

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Teriparatide or alendronate in glucocorticoid-induced osteoporosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Pre-existing fractures and bone mass predict vertebral fracture incidence in women

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Total body bone measurements: a cross-sectional study in children with acute lymphoblastic leukemia during and following completion of therapy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Impaired development of bone mineral density during chemotherapy: a prospective analysis of 46 children newly diagnosed with cancer

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Reduced bone density at completion of chemotherapy for a malignancy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Prevalence of abnormal bone density of pediatric patients prior to blood or marrow transplant

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Bone mineral density in patients undergoing bone marrow transplantation for myeloid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Bone mass after treatment of malignant lymphoma in childhood

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Bone mineral density in pediatric transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Bone mineral density in children with thalassaemia major: determining factors and effects of bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Bone mineral density and osteonecrosis in survivors of childhood allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Uncritical use of bone mineral density in absorptiometry may lead to size-related artifacts in the identification of bone mineral determinants

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Interpretation of whole body dual energy X-ray absorptiometry measures in children: comparison with peripheral quantitative computed tomography

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Discrepancies in pediatric bone mineral density reference data: potential for misdiagnosis of osteopenia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Pubertal development and final height after autologous bone marrow transplantation for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Disturbances of growth and endocrine function after busulphan-based conditioning for haematopoietic stem cell transplantation during infancy and childhood

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Pubertal development and growth after total-body irradiation and bone marrow transplantation for haematological malignancies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Dual-energy X-ray aborptiometry assessment in children and adolescents with diseases that may affect the skeleton: the 2007 ISCD Pediatric Official Positions

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Bisphosphonate therapy for reduced bone mineral density in children with chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Bone mineral density deficits in survivors of childhood cancer: long-term follow-up guidelines and review of the literature

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Approach to the patient with transplantation-related bone loss

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Of mice and men: divergent risks of teriparatide-induced osteosarcoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.198

7 January 2021

Identifiers

DOI

10.1038/BMT.2010.198

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20729922%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference